Boston Scientific
565 hedge funds and large institutions have $29.4B invested in Boston Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 200 increasing their positions, 204 reducing their positions, and 39 closing their positions.
68% more call options, than puts
Call options by funds: $87.9M | Put options by funds: $52.3M
64% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 39
4% more funds holding
Funds holding: 543 → 565 (+22)
1% less capital invested
Capital invested by funds: $29.5B → $29.4B (-$170M)
2% less repeat investments, than reductions
Existing positions increased: 200 | Existing positions reduced: 204
1.34% less ownership
Funds ownership: 93.16% → 91.82% (-1.3%)
30% less funds holding in top 10
Funds holding in top 10: 23 → 16 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$188M |
| 2 |
Two Sigma Investments
New York
|
+$102M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$100M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$341M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$235M |
| 3 |
GE
General Electric
Evendale,
Ohio
|
-$167M |
| 4 |
O
OrbiMed
New York
|
-$141M |
| 5 |
Millennium Management
New York
|
-$82.4M |
BSX Hedge Fund Activity: Q3 2016 in Review
565 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2016, worth a combined $29.4B — down 0.58% from $29.5B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new BSX positions and 39 closed out — a net gain of 25 holders — while 200 added to existing stakes and 204 trimmed.
The largest buyer was State Street, adding an estimated $188M. The largest seller was Wellington Management Group, cutting an estimated $341M.
- 565 institutional investors held Boston Scientific (BSX) as of Q3 2016, up from 543 in Q2 2016.
- Funds reported $29.4B of Boston Scientific stock for Q3 2016, down 0.58% quarter-over-quarter.
- 64 funds opened new Boston Scientific positions in Q3 2016 and 39 closed out, a net change of +25 holders.
- The largest Boston Scientific buyer in Q3 2016 was State Street, an estimated $188M added.
- The largest Boston Scientific seller in Q3 2016 was Wellington Management Group, an estimated $341M sold.
Based on aggregated 13F filings for Q3 2016.